ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.97
0.33 (50.55%)
At close: Aug 18, 2025, 3:59 PM
50.55% (1D)
| Bid | 0.82 |
| Market Cap | 51.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -130.02M |
| EPS (ttm) | -2.16 |
| PE Ratio (ttm) | -0.45 |
| Forward PE | -0.58 |
| Analyst | Buy |
| Ask | 1 |
| Volume | 14,442,699 |
| Avg. Volume (20D) | 524,574 |
| Open | 0.68 |
| Previous Close | 0.64 |
| Day's Range | 0.66 - 1.04 |
| 52-Week Range | 0.40 - 2.73 |
| Beta | 1.14 |
About ALXO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALXO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALXO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-19.08%
ALX Oncology Holdings shares are trading lower. Th...
Unlock content with
Pro Subscription
5 months ago
+25.96%
ALX Oncology Holdings shares are trading higher after Piper Sandler and Jefferies upgraded their respective price targets on the stock.
6 days ago · seekingalpha.com
ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call TranscriptALX Oncology Holdings Inc. (NASDAQ:ALXO ) Q2 2025 Earnings Conference Call August 12, 2023 4:30 AM ET Company Participants Alan Bart Sandler - Chief Medical Officer Harish Shantharam - Chief Financial...